U.S. Professional Services Stock News

NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Is Ligand Pharmaceuticals (LGND) Still Attractive After Its 165.7% Three Year Share Price Surge

If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business. The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date. Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Sportradar Expands iGaming Reach As Playradar And Hard Rock Tie Deepen

Sportradar Group (NasdaqGS:SRAD) has introduced Playradar, a new iGaming brand that combines live sports streaming with casino style gaming experiences. The company has also expanded its relationship with Hard Rock Bet to include official PGA TOUR and UFC data plus more advanced in play betting features. These updates extend Sportradar's role beyond core sports data into hybrid gaming products while deepening ties with a major US betting operator. Sportradar Group, trading at $17.15, is...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

How FGC-Linked Inflows and Retail Trading Momentum At XP (XP) Has Changed Its Investment Story

On March 16, 2026, at its Global Conference, XP Inc. drew attention as analysts highlighted a stronger-than-expected start to the year driven by heavier retail equity trading and anticipated client reimbursements from Brazil’s deposit insurance fund (FGC) flowing back into XP’s platform. The interesting angle for investors is how these FGC-related inflows, if reinvested into fixed-income products, could generate upfront commissions that temporarily enhance XP’s revenue mix and fee...
NYSE:CFR
NYSE:CFRBanks

Does Slowing Revenue And Softer Book Value Expectations Reframe Frost Bank’s Capital Story For CFR?

In recent commentary on Cullen/Frost Bankers, analysts highlighted that while Frost Bank’s prior quarterly results were solid, its revenue growth over the past two years has slowed relative to peers and its own five-year trend. An interesting takeaway is that consensus now points to a projected decline in tangible book value per share over the next 12 months, raising fresh questions about the bank’s capital generation and profitability outlook. Next, we’ll examine how slowing revenue growth...
NYSE:APTV
NYSE:APTVAuto Components

Aptiv Leadership Shift In Intelligent Systems And What It Means For Valuation

Aptiv (NYSE:APTV) announced that Javed Khan, Executive Vice President and President of Intelligent Systems, is resigning to become CEO of a software and AI company. CEO Kevin Clark will take on Khan's responsibilities on an interim basis while Aptiv searches for a successor. Aptiv shares recently closed at $67.04, with the stock showing a 10.6% gain over the past year, a 14.5% decline year to date, and a 40.2% decline over three years. The Intelligent Systems segment is an important area...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Is It Time To Reconsider Corpay (CPAY) After Recent Share Price Weakness

If you are wondering whether Corpay's current share price reflects its underlying worth, you are not alone. This article focuses squarely on what you might be paying for each dollar of quality in the business. Corpay recently closed at US$284.93, with returns of a 0.9% decline over 7 days, a 13.7% decline over 30 days, a 5.2% decline year to date, a 17.8% decline over 1 year, alongside longer term returns of 35.1% over 3 years and 1.9% over 5 years. Recent coverage has highlighted Corpay in...
NYSE:POR
NYSE:PORElectric Utilities

Is Portland General Electric (POR) Fairly Priced After Recent Grid Focus And 22% Annual Gain?

Wondering if Portland General Electric at around US$51.71 is offering fair value right now, or if the recent share price leaves something on the table for you? The stock is up 1.5% over the past week and 6.7% year to date, while the last 12 months show a 22.0% return despite a 3.3% pullback over the past month. Recent attention on regulated utilities and the broader power grid story has kept Portland General Electric in focus, as investors weigh the role of electricity providers in long term...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

A Look At Monte Rosa Therapeutics (GLUE) Valuation After Johnson & Johnson MRT-2359 Trial Supply Agreement

Monte Rosa Therapeutics (GLUE) has moved into focus after signing a supply agreement with Johnson & Johnson to evaluate MRT-2359 plus ERLEADA in a planned Phase 2 trial for metastatic castration-resistant prostate cancer. See our latest analysis for Monte Rosa Therapeutics. Alongside the Johnson & Johnson supply agreement and fresh MRT-2359 data, Monte Rosa’s share price has eased recently. The stock has a 30 day share price return of 15% and a 90 day share price return decline of 11%. At the...
NYSE:BKD
NYSE:BKDHealthcare

Brookdale’s Pet Friendly Award Adds New Angle To Undervalued Stock Story

Brookdale Senior Living (NYSE:BKD) has been recognized as a "Best Pet Workplace" by WUF World. The company is the first senior living provider to receive this designation. The award highlights Brookdale's focus on pet friendly policies for residents and associates. Brookdale Senior Living, trading at $13.82, now carries a "Best Pet Workplace" label that sets it apart within the senior living space. Over the past year, the stock has returned 124.7%, and it is up 27.5% year to date. This may...
NasdaqGS:CPB
NasdaqGS:CPBFood

How Investors May Respond To Campbell's (CPB) Storm-Hit Q2 and Mounting Demand Pressures

Earlier in March, Campbell's reported fiscal Q2 2026 results showing lower net sales and EBIT, as storms in January disrupted shipments and lifted supply chain costs. These results come amid two years of falling unit sales and a projected 2.6% sales decline over the next 12 months, underscoring demand pressure in Campbell's core categories. Next, we’ll examine how weaker demand and weather-related supply chain disruptions might reshape Campbell's previously outlined investment...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

Is WD-40 (WDFC) Fairly Priced After Recent Share Price Weakness?

Wondering whether WD-40 at around US$201 a share looks expensive, cheap, or somewhere in between? This article breaks down what the current price really represents. The stock is up 2.3% year to date, but that sits alongside a 5.9% decline over the last week, an 18.1% decline over the last month, and a 15.3% decline over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on WD-40 as a long established brand in household products,...
NYSE:PIPR
NYSE:PIPRCapital Markets

Four‑for‑One Stock Split and Share Increase Could Be A Game Changer For Piper Sandler (PIPR)

On March 23, 2026, Piper Sandler Companies filed an amendment to its Delaware certificate of incorporation to complete a four-for-one forward stock split of its common stock, maintain the par value at US$0.01, increase authorized shares from 100,000,000 to 400,000,000, and begin split-adjusted trading on March 24 under a new CUSIP. This move materially increases the share count and lowers the price per share, which can broaden investor accessibility and enhance trading liquidity without...
NYSE:MRP
NYSE:MRPSpecialized REITs

Millrose Properties Expands Unsecured Credit And Reshapes Balance Sheet Flexibility

Millrose Properties (NYSE:MRP) has amended its credit facility, expanding it into a larger unsecured structure. The company is transitioning from a secured facility to an unsecured framework with added term loan capacity. This shift represents a material change in Millrose's capital structure and liquidity profile. For a real estate focused business like Millrose Properties, access to flexible credit can be just as important as the properties it owns. The move toward an unsecured facility...
NYSE:UAN
NYSE:UANChemicals

Why CVR Partners (UAN) Is Up 7.2% After Strait of Hormuz Disruptions Tighten Fertilizer Supply

Recent disruptions to shipping through the Strait of Hormuz have tightened global fertilizer supply, pushing up prices and boosting prospects for nitrogen-focused producers such as CVR Partners. Analysts at Bank of America have highlighted that these elevated earnings for fertilizer makers may be short-lived, as industry conditions typically cycle back toward more normal levels once geopolitical tensions ease. We’ll now consider how the prospect of short-term windfall profits from tighter...
NYSE:BFS
NYSE:BFSRetail REITs

A Look At Saul Centers (BFS) Valuation After Recent Share Price Weakness

Event context and recent performance Saul Centers (BFS) has attracted fresh attention after recent share price moves. The stock closed at $32.34, with a 1-day return of a 1% decline, a flat performance over the week, and a 5.8% decline over the past month. See our latest analysis for Saul Centers. That recent 5.8% one month share price decline sits against a modest 2.5% 90 day share price return and a 2.5% year to date share price gain. The 1 year total shareholder return is slightly...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Is It Too Late To Consider Materion (MTRN) After A 70% One Year Rally?

Investors may be wondering whether Materion, at around US$141 a share, still offers value or if most of the potential upside has already been priced in. The stock has moved sharply, with a 7.1% gain over the last week, a 12.5% decline over the last month, and returns of 10.0% year to date and 70.4% over the past year. These swings have kept the stock on many investors' watchlists, as price action alone does not explain what is driving sentiment. Recent coverage has focused on how the...
NYSE:PNR
NYSE:PNRMachinery

Pentair Chair Transition Raises Questions On Governance And Capital Priorities

Pentair (NYSE:PNR) announced the retirement of long-serving Chair David A. Jones after more than two decades on the Board and eight years as Chair. T. Michael Glenn, an independent director with extensive board experience, has been appointed as the new Chair. The transition marks a planned change in board leadership and governance oversight at Pentair. Pentair focuses on water treatment and fluid management solutions, an area that sits at the intersection of infrastructure, sustainability...
NYSE:GGG
NYSE:GGGMachinery

How Graco’s Earnings Beat Amid Flat Sales Will Impact Graco (GGG) Investors

Graco recently reported a past quarter with revenues up 8.1% year on year and earnings exceeding analysts’ EBITDA expectations, reflecting solid near‑term execution. However, flat sales over the last two years, declining earnings per share, and shrinking returns on capital have raised concerns about longer‑term growth and profitability. We’ll now explore how these signs of muted long‑term growth, despite a recent earnings beat, may influence Graco’s broader investment narrative. Outshine the...
NYSE:MKC
NYSE:MKCFood

Is McCormick’s (MKC) Black Currant Push a Sign of Deeper Brand Strategy Shifts?

Earlier this week, McCormick expanded its 2026 Flavor of the Year campaign by rolling out Black Currant seasoning and finishing sugar, and by hosting Sensoria: The Black Currant Experience in New York, a multisensory event that brought the flavor trend to consumers and culinary professionals. This push around Black Currant underlines how McCormick uses trend-driven product innovation and immersive brand experiences to deepen engagement with both home cooks and foodservice partners. Next,...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

The Bull Case For Merit Medical Systems (MMSI) Could Change Following Medtronic ViaVerte Distribution Deal - Learn Why

On 24 March 2026, Medtronic announced a distribution agreement with Merit Medical Systems to offer ViaVerte, an FDA-cleared, minimally invasive basivertebral nerve ablation system for chronic vertebrogenic lower back pain, extending an existing supply relationship between the two companies. This agreement gives Merit access to Medtronic’s broad pain management distribution network, potentially increasing physician adoption of ViaVerte and reinforcing Merit's position in outpatient spine...